AQST - Aquestive Therapeutics, Inc.
IEX Last Trade
3.615
0.025 0.692%
Share volume: 14,803
Last Updated: Thu 26 Dec 2024 08:29:43 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$3.59
0.03
0.70%
Summary score
44%
Profitability
41%
Dept financing
37%
Liquidity
75%
Performance
40%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
19.07%
Return on assets
-13.41%
Return on sales
-76.05%
Return on invested capital
-68.83%
Total debt ratio
229.73%
Debt ratio change over timeo
0.69%
Current Ratio
2.07%
Quick Ratio
1.87%
Cash Position Ratio
1.3%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
12.59%
Return on assets
-6.28%
Return on sales
-38.5%
Return on invested capital
290.76%
Total debt ratio
243.44%
Debt ratio change over timeo
1.65%
Current Ratio
2.83%
Quick Ratio
2.52%
Cash Position Ratio
2.05%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
35.34%
Return on assets
-6.92%
Return on sales
-74.31%
Return on invested capital
670.22%
Total debt ratio
128.03%
Debt ratio change over time
-0.71%
Current Ratio
6.28%
Quick Ratio
5.85%
Cash Position Ratio
5.27%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-99.48%
Return on assets
-103.94%
Return on sales
-113.99%
Return on invested capital
560.73%
Total debt ratio
68.62%
Debt ratio change over time
0.69%
Current Ratio
0.11%
Quick Ratio
-0.03%
Cash Position Ratio
-0.38%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AQST | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 19.07% | 18.83% | 17.34% | 7.6% |
| Return on assets | -13.41% | 4.16% | 8.21% | 3.22% |
| Return on sales | -76.05% | 28.21% | 41.18% | 25.37% |
| Return on invested capital | -68.83% | 9.79% | -219.55% | 7.46% |
| Profitability | 25% | 79% | 73% | 54% |
| Total debt ratio | 229.73% | 82.89% | 55.88% | 60.02% |
| Debt ratio change over time | 0.69% | -4.38% | -0.73% | -33.74% |
| Dept financing | 50% | 9% | 6% | 7% |
| Current Ratio | 2.83% | 1.12% | 0% | 1.16% |
| Quick Ratio | 2.52% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 2.05% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 31% | 31% | 41% |
| Short-term ratios | AQST | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 12.59% | 13.31% | 0% | 13.48% |
| Return on assets | -6.28% | 4.72% | 0% | 3.05% |
| Return on sales | -38.5% | 31.4% | 0% | 25.56% |
| Return on invested capital | 290.76% | 10.68% | 0% | 13.96% |
| Profitability | 48% | 76% | 0% | 63% |
| Total debt ratio | 243.44% | 80.89% | 0% | 59.04% |
| Debt ratio change over time | 1.65% | -41.82% | 0% | 7.13% |
| Dept financing | 31% | 8% | 0% | 31% |
| Current Ratio | 2.83% | 1.12% | 0% | 1.16% |
| Quick Ratio | 2.52% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 2.05% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 20% | 0% | 26% |